Cargando…

Genetically determined blood pressure, antihypertensive medications, and risk of Alzheimer’s disease: a Mendelian randomization study

BACKGROUND: Observational studies suggest that the use of antihypertensive medications (AHMs) is associated with a reduced risk of Alzheimer’s disease (AD); however, these findings may be biased by confounding and reverse causality. We aimed to explore the effects of blood pressure (BP) and lowering...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ou, Ya-Nan, Yang, Yu-Xiang, Shen, Xue-Ning, Ma, Ya-Hui, Chen, Shi-Dong, Dong, Qiang, Tan, Lan, Yu, Jin-Tai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874453/ https://www.ncbi.nlm.nih.gov/pubmed/33563324 http://dx.doi.org/10.1186/s13195-021-00782-y

Ejemplares similares

Herpesvirus infections and Alzheimer’s disease: a Mendelian randomization study
por: Huang, Shu-Yi, et al.
Publicado: (2021)

Fasting blood glucose and cerebrospinal fluid Alzheimer’s biomarkers in non-diabetic cognitively normal elders: the CABLE study
por: Ou, Ya-Nan, et al.
Publicado: (2020)

Association of cerebrospinal fluid neurogranin levels with cognition and neurodegeneration in Alzheimer’s disease
por: Xue, Mei, et al.
Publicado: (2020)

Effects of blood pressure and antihypertensive drugs on osteoarthritis: a mendelian randomized study
por: Zhang, Yinzhen, et al.
Publicado: (2023)

Associations of cardiovascular risk factors and lifestyle behaviors with neurodegenerative disease: a Mendelian randomization study
por: Huang, Liang-Yu, et al.
Publicado: (2023)

High pulse pressure is a risk factor for prodromal Alzheimer’s disease: a longitudinal study
por: Shi, Wen-Yan, et al.
Publicado: (2020)

Association between methylation of BIN1 promoter in peripheral blood and preclinical Alzheimer’s disease
por: Hu, Hao, et al.
Publicado: (2021)

Cortical structure and the risk for Alzheimer’s disease: a bidirectional Mendelian randomization study
por: Wu, Bang-Sheng, et al.
Publicado: (2021)

A panel of blood lipids associated with cognitive performance, brain atrophy, and Alzheimer's diagnosis: A longitudinal study of elders without dementia
por: Ma, Ya‐Hui, et al.
Publicado: (2020)

Causal effects of serum sex hormone binding protein levels on the risk of amyotrophic lateral sclerosis: a mendelian randomization study
por: Ou, Ya-Nan, et al.
Publicado: (2022)

Metabolically healthy obesity reduces the risk of Alzheimer’s disease in elders: a longitudinal study
por: Ma, Ling-Zhi, et al.
Publicado: (2019)

Genome-wide association study of white matter hyperintensity volume in elderly persons without dementia
por: Guo, Yu, et al.
Publicado: (2020)

Repurposing antihypertensive drugs for the prevention of Alzheimer’s disease: a Mendelian randomization study
por: Walker, Venexia M, et al.
Publicado: (2019)

Genetically determined low income modifies Alzheimer’s disease risk
por: Wang, Rong-Ze, et al.
Publicado: (2021)

Genome-wide association study of hippocampal atrophy rate in non-demented elders
por: Guo, Yu, et al.
Publicado: (2019)

FDG-PET as an independent biomarker for Alzheimer’s biological diagnosis: a longitudinal study
por: Ou, Ya-Nan, et al.
Publicado: (2019)

Association of serum Apolipoprotein B with cerebrospinal fluid biomarkers of Alzheimer’s pathology
por: Hu, Hao, et al.
Publicado: (2020)

Associations of healthy lifestyles with cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact older adults: the CABLE study
por: Hou, Xiao-He, et al.
Publicado: (2021)

Longitudinal plasma phosphorylated tau 181 tracks disease progression in Alzheimer’s disease
por: Chen, Shi-Dong, et al.
Publicado: (2021)

Discordant Alzheimer's neurodegenerative biomarkers and their clinical outcomes
por: Guo, Yu, et al.
Publicado: (2020)

Dynamic changes of CSF sTREM2 in preclinical Alzheimer’s disease: the CABLE study
por: Ma, Ling-Zhi, et al.
Publicado: (2020)

Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status
por: Shen, Xue-Ning, et al.
Publicado: (2021)

Association of peripheral immunity with cognition, neuroimaging, and Alzheimer’s pathology
por: Hou, Jia-Hui, et al.
Publicado: (2022)

Genetically determined blood pressure, antihypertensive drug classes, and risk of stroke subtypes
por: Georgakis, Marios K., et al.
Publicado: (2020)

Genome-wide association study identifies SIAH3 locus influencing the rate of ventricular enlargement in non-demented elders
por: Li, Xian, et al.
Publicado: (2019)

Deamidation-related blood biomarkers show promise for early diagnostics of neurodegeneration
por: Wang, Jijing, et al.
Publicado: (2022)

Subtle cognitive impairment as a marker of Alzheimer's pathologies and clinical progression in cognitively normal individuals
por: Shen, Xue‐Ning, et al.
Publicado: (2021)

Investigating causal relationships between exposome and human longevity: a Mendelian randomization analysis
por: Huang, Shu-Yi, et al.
Publicado: (2021)

Association between Life’s Simple 7 and cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact adults: the CABLE study
por: Zhao, Yong-Li, et al.
Publicado: (2022)

Late-life obesity is a protective factor for prodromal Alzheimer’s disease: a longitudinal study
por: Sun, Zhen, et al.
Publicado: (2020)

Causal Relations between Exposome and Stroke: A Mendelian Randomization Study
por: Li, Hong-Qi, et al.
Publicado: (2022)

The dynamics of plasma biomarkers across the Alzheimer’s continuum
por: Guo, Yu, et al.
Publicado: (2023)

Blood pressure response to commonly administered antihypertensives for severe inpatient hypertension
por: Ghazi, Lama, et al.
Publicado: (2022)

Synergism of antihypertensives and cholinesterase inhibitors in Alzheimer's disease
por: Hu, Ziheng, et al.
Publicado: (2018)

Severe inpatient hypertension prevalence and blood pressure response to antihypertensive treatment
por: Ghazi, Lama, et al.
Publicado: (2022)

High Blood Pressure and Intraocular Pressure: A Mendelian Randomization Study
por: Plotnikov, Denis, et al.
Publicado: (2022)

Time spent in outdoor light is associated with the risk of dementia: a prospective cohort study of 362094 participants
por: Ma, Ling-Zhi, et al.
Publicado: (2022)

Plasma amyloid, tau, and neurodegeneration biomarker profiles predict Alzheimer's disease pathology and clinical progression in older adults without dementia
por: Shen, Xue‐Ning, et al.
Publicado: (2020)

Genetically predicted hypertension, antihypertensive drugs, and risk of erectile dysfunction: a Mendelian randomization study
por: Zhao, Cong, et al.
Publicado: (2023)

Associations of the cerebrospinal fluid hepatocyte growth factor with Alzheimer’s disease pathology and cognitive function
por: Zhao, Li-Jing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nlpmoih458fmmgpf4e8fos5rec